article thumbnail

STAT+: UnitedHealth continues making stealthy deals, pushing deeper into medical care as scrutiny mounts

STAT

And just like in 2023, UnitedHealth has prioritized outpatient surgery centers.    UnitedHealth acquired full or partial ownership stakes in more than 100 surgery centers in 2024, according to a STAT review of UnitedHealth’s newest annual financial documents.

article thumbnail

ICYMI: Cancer death rate continues to decline due to treatment advances

PhRMA

Earlier this month, the American Cancer Society (ACS) released its annual report, Cancer Statistics 2023, finding the overall cancer mortality rate has declined 33% since peaking in 1991, leading to an estimated 3.8 This report is the latest to document this progress. million averted cancer deaths over this period.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

6 research and development life sciences predictions for 2023

pharmaphorum

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023. Data will unlock clinical and economic value in Europe’s challenging landscape.

article thumbnail

FDA Publishes Its Draft Strategy Document on Innovative Manufacturing Technologies

The FDA Law Blog

FDA-2024-N-3945 ] announcing the publication of a draft strategy document, for public comment, outlining specific actions FDA plans to take to facilitate the use of innovative manufacturing technologies. It was at this workshop that the agency committed to issuing a draft strategy document, for public comment.

article thumbnail

Measles cases continue to rise in US amid lagging vaccination rates

Pharmaceutical Technology

According to the CDC, over 64 cases of measles have been documented in the US in 2024, already exceeding 2023's total of 58.

article thumbnail

FDA Issues Two Guidance Documents on Food Allergen Labeling Requirements

The FDA Law Blog

Food and Drug Administration (FDA) issued two guidance documents, one draft and one final, on food allergen labeling requirements. 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g., 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g.,

article thumbnail

Discover, Delve, and Develop: Expert Workshops at the 2023 ISPE Annual Meeting & Expo

ISPE

Contamination Control Strategy: With the implementation of the revised Annex 1 slated for 25 August, 2023, concerns around compliance surrounding Annex 1 are growing and will be at the forefront of the 2023 ISPE Annual Meeting & Expo. At the core of the updated Annex 1 is the heightened focus on the CCS.